TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-11
DOI
10.1038/s41598-017-05845-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells
- (2016) Yumin Oh et al. HEPATOLOGY
- Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL
- (2016) Fengyun Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Receptor-specific TRAIL as a means to achieve targeted elimination of activated hepatic stellate cells
- (2016) Mohammad Arabpour et al. JOURNAL OF DRUG TARGETING
- The role of innate immunity in the immunopathology and treatment of HBV infection
- (2016) Mala K. Maini et al. JOURNAL OF HEPATOLOGY
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- Natural Killer Cells and Liver Fibrosis
- (2016) Frank Fasbender et al. Frontiers in Immunology
- CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
- (2016) Kerstin A. Stegmann et al. Scientific Reports
- Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
- (2015) L O'Leary et al. ONCOGENE
- Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells
- (2015) Adil El Taghdouini et al. Oncotarget
- Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
- (2014) Ali A Mokdad et al. BMC Medicine
- Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
- (2013) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
- (2013) Tamar Mchedlidze et al. IMMUNITY
- Death Receptor-Ligand Systems in Cancer, Cell Death, and Inflammation
- (2013) H. Walczak Cold Spring Harbor Perspectives in Biology
- Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
- (2012) Dimitra Peppa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
- (2012) Andreas Glässner et al. LABORATORY INVESTIGATION
- NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis
- (2011) Chamutal Gur et al. GUT
- TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT
- (2011) Najoua Lalaoui et al. PLoS One
- Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
- (2010) Dimitra Peppa et al. PLoS Pathogens
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started